The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A prospective phase II study of biweekly S-1, leucovorin and gemcitabine in elderly patients with locally advanced or metastatic pancreatic adenocarcinoma.
 
Li-Yuan Bai
Honoraria - CStone Pharmaceuticals; Ipsen; Lilly; Ono Pharmaceutical; Pfizer; SynCoreBio
Consulting or Advisory Role - Bristol-Myers Squibb
 
Chung-Pin Li
No Relationships to Disclose
 
Yan-Shen Shan
No Relationships to Disclose
 
Shih-Chang Chuang
No Relationships to Disclose
 
Jen-Shi Chen
Consulting or Advisory Role - Ono Pharmaceutical
Research Funding - Astellas Pharma; AstraZeneca; Janssen; Lilly; Merck KGaA; MSD Oncology; Oncologie; Ono Pharmaceutical; Roche; Senhwa Biosciences; SynCoreBio; TTY Biopharm
 
Nai-Jung Chiang
Speakers' Bureau - AstraZeneca; MSD; Ono Pharmaceutical; TTY Biopharm
 
Yen-Yang Chen
No Relationships to Disclose
 
Hsiao-Hui Tsou
No Relationships to Disclose
 
Mei-Hsing Chuang
No Relationships to Disclose
 
Chang-Fang Chiu
No Relationships to Disclose
 
Tsang-Wu Liu
No Relationships to Disclose
 
Li-Tzong Chen
Leadership - ScinoPharm
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; CStone Pharmaceuticals; Ipsen; Lilly; MSD; Novartis; Ono Pharmaceutical; SynCoreBio; Taivex Therapeutics; TTY Biopharm
Research Funding - ACT Genomics (Inst); Bristol-Myers Squibb (Inst); Merck Serono (Inst); Novartis (Inst); Pfizer (Inst); Polaris (Inst); SynCoreBio (Inst); TTY Biopharm (Inst)
Patents, Royalties, Other Intellectual Property - HuniLife Taiwan
(OPTIONAL) Uncompensated Relationships - Onward Therapeutics